首页 | 本学科首页   官方微博 | 高级检索  
检索        

急性心肌梗死患者应用尿激酶早期溶栓治疗的临床体会
引用本文:梁汉林.急性心肌梗死患者应用尿激酶早期溶栓治疗的临床体会[J].中国当代医药,2012(4):24-25.
作者姓名:梁汉林
作者单位:广西壮族自治区罗城仫佬族自治县中医医院内科
摘    要:目的探讨基层医院应用尿激酶溶栓治疗急性心肌梗死的临床疗效。方法选择2005年2月~2010年12月收治的AMI患者31例,均应用尿激酶进行早期溶栓治疗。结果本组再通率为70.9%(22/31),发病后溶栓时间愈早再通率愈高;患者胸痛症状、血清心肌酶谱及心电图等指标明显改善。结论尿激酶溶栓治疗急性心肌梗死安全、有效,尤其适用于基层医院的救治。

关 键 词:急性心肌梗死  静脉溶栓  尿激酶  治疗

The clinical experience of early intravenous thrombolysis with urokinase on acute myocardial infrarction in the primary hospital
Authors:LIANG Hanlin
Institution:LIANG Hanlin Department of Internal Medicine,the Traditional Chinese Medicine Hospital of Luocheng Mulam Nationality in Guangxi Zhuang Autonomous Region,Luocheng 546400,China
Abstract:Objective To investigate the clinical effect of urokinase for treating acute myocardial infarction.Methods Chose 31 patients with AMI from February 2005 to December 2010 in our hospital,who were treated with early intravenous thrombolysis with urokinase.Results The total recanalization rate was 70.9%(22/31),the earlier time of incidence to the beginning of thrombolysis,and then the higher rate of recanalization.The clinical indicators such as chest pain sympotoms,serum myocardial enzymes and ECG were significantly improved.Conclusion It is safe and effective that early intravenous thrombolysis with urokinase in acute myocardial infarction,and especially apply for trratment in the primary hospital.
Keywords:Acute myocardial infrarction  Intravenous thrombolysis  Urokinase  Treatment
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号